Target intelligence / Profile preview

Kallikrein (KLK)

Target
KLK
Molecular classification
Enzyme, Serine Protease
01

Overview

Kallikreins are a subgroup of serine proteases involved in various physiological processes including blood pressure regulation, inflammation, and semen liquefaction. They are synthesized as inactive pro-proteins and activated by proteolytic cleavage. Dysregulation of kallikreins has been implicated in cancer, cardiovascular disorders, and inflammatory conditions, making them potential therapeutic targets and biomarkers.

Other names
Plasma KallikreinTissue KallikreinsKLKB1KLK1KLK2KLK3KLK4KLK5KLK6KLK7KLK8KLK9KLK10KLK11KLK12KLK13KLK14KLK15
02

Mechanism of action

Kallikreins are serine proteases that cleave peptide bonds in proteins, particularly kininogens, to release kinins like bradykinin, which mediates vasodilation and inflammation. They also play roles in semen liquefaction and extracellular matrix remodeling.

03

Biological functions

Blood pressure regulationInflammation controlSemen liquefactionExtracellular matrix remodelingSkin desquamationAngiogenesis
04

Disease associations

CancerCardiovascular disordersInflammatory conditions
05

Safety considerations

Off-target effects due to broad substrate specificityPotential for hypotensive effectsUnintended activation of inflammatory pathways
06

Biomarkers

KLK3 (Prostate-Specific Antigen - PSA) for prostate cancerKLKs as potential biomarkers in various cancers

Beyond the preview

Go deeper on Kallikrein (KLK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kallikrein (KLK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call